Skip to content

Insider · CIK 0001674993

Christopher Simon

ceopresidentofficerdirector

Files at HAE (HAEMONETICS CORP), SHC (Sotera Health Co). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 30, 2025HAE
HAEMONETICS CORP
AGrant or award
Common Stock
+66,666$0.00$0401,778Jun 3, 2025
May 30, 2025HAE
HAEMONETICS CORP
FTax withholding
Common Stock
-26,234$69.38$1.8M375,544Jun 3, 2025
May 22, 2025SHC
Sotera Health Co
AGrant or award
Common Stock, $0.01 par value per share ("Common Stock")
+19,132$0.00$019,132May 27, 2025
May 16, 2025HAE
HAEMONETICS CORP
AGrant or award
Common Stock
+21,405--335,112May 20, 2025
May 16, 2025HAE
HAEMONETICS CORP
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+46,342$0.00$046,342May 20, 2025
May 15, 2025HAE
HAEMONETICS CORP
FTax withholding
Common Stock
-2,391$69.38$166k320,796May 19, 2025
May 16, 2025HAE
HAEMONETICS CORP
FTax withholding
Common Stock
-7,089$70.31$498k313,707May 19, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Christopher Simon: insider trades and track record | InsiderTell